Seguir
Guilherme Sacchi de Camargo Correia Correia
Guilherme Sacchi de Camargo Correia Correia
E-mail confirmado em mayo.edu
Título
Citado por
Citado por
Ano
Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature
R Galhardoni, GS Correia, H Araujo, LT Yeng, DT Fernandes, ...
Archives of physical medicine and rehabilitation 96 (4), S156-S172, 2015
1642015
Normative data of cortical excitability measurements obtained by transcranial magnetic stimulation in healthy subjects
AS Cueva, R Galhardoni, RG Cury, DC Parravano, G Correa, H Araujo, ...
Neurophysiologie Clinique/Clinical Neurophysiology 46 (1), 43-51, 2016
592016
Outcomes of TP53 mutated AML with evolving frontline therapies: impact of allogeneic stem cell transplantation on survival
MD Patel, Y Abaza, JP Bewersdorf, AN Saliba, GSDC Correia, A Duvall, ...
252022
Estimulação magnética transcraniana e aplicabilidade clínica: perspectivas na conduta terapêutica neuropsiquiátrica
HA Araújo, RF Iglesio, GS de Camargo Correia, DTRM Fernandes, ...
Revista de Medicina 90 (1), 3-14, 2011
242011
Addressing a new challenge in chronic lymphocytic leukemia: outcomes of therapies after exposure to both a covalent Bruton's tyrosine kinase inhibitor and venetoclax
MC Thompson, LE Roeker, CC Coombs, JL Jensen, M Kamdar, ...
Blood 138, 2628, 2021
122021
Emerging targeted therapies in advanced non-small-cell lung cancer
S Li, GS de Camargo Correia, J Wang, R Manochakian, Y Zhao, Y Lou
Cancers 15 (11), 2899, 2023
72023
Obstetric and perioperative management of patients with factor XI deficiency: a retrospective observational study
S Handa, M Sterpi, G Sacchi De Camargo Correia, DS Frankel, Y Beilin, ...
Blood Advances 7 (10), 1967-1975, 2023
42023
Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia
T Badar, MR Litzow, RM Shallis, A Patel, AN Saliba, M Burkart, ...
Cancer 129 (6), 934-945, 2023
32023
Multicenter analysis of treatment and outcomes for patient with TP53 mutated AML in the era of novel therapies; significant impact of allogeneic stem cell transplantation on …
T Badar, MR Litzow, RM Shallis, JP Bewersdorf, A Saliba, M Stahl, ...
Blood 138, 797, 2021
32021
Primary pulmonary NUT carcinoma: case illustration and updated review of literature
BA Costa, A Maraveyas, MH Wilkoff, GS de Camargo Correia, PT de Lara, ...
Clinical Lung Cancer 23 (4), e296-e300, 2022
22022
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid …
T Badar, A Nanaa, E Atallah, RM Shallis, SCC Guilherme, AD Goldberg, ...
Blood Cancer Journal 14 (1), 32, 2024
12024
Comparing anticoagulation strategies for venous thromboembolism associated with active cancer: a systematic review and meta-analysis
T Fujisaki, D Sueta, E Yamamoto, C Buckley, ...
Cardio Oncology 6 (1), 99-113, 2024
12024
Estimulação magnética transcraniana e aplicabilidade clínica: perspectivas na conduta terapêutica neuropsiquiátrica
HA Araújo, RF Iglesio, GSC Correia, MA Marcolim, MJ Teixeira, ...
Revista de Medicina 89 (supl.), 13, 2010
12010
The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer
GS de Camargo Correia, Y Zhao, R Manochakian, Y Lou
Frontiers in Oncology 14, 2024
2024
Achievement of Undetectable BCR:: ABL1 (uBCR:: ABL1) Is Predictive of Improved Survival in Philadelphia Chromosome Positive (Ph+ ve) Acute Lymphoblastic Leukemia (ALL) Patients …
T Badar, R Narra, A Mims, RM Shallis, GSDC Correia, C Hunter, VK Kota, ...
Blood 142, 1464, 2023
2023
Comparable Survival of Treatment Naïve TP53 Mutated Acute Myeloid Leukemia Treated with Hypomethylating Agent Compared to Hypomethylating Agent Plus Venetoclax Based Therapy
T Badar, EL Atallah, RM Shallis, AA Patel, GSDC Correia, AD Goldberg, ...
Blood 142, 592, 2023
2023
Uptake of palliative care services in patients with non-small cell lung cancer receiving immune checkpoint inhibitor therapy: The Mayo Clinic Florida experience.
T Pai, S Li, G Sacchi de Camargo Correia, OM Mosalem, NE Wiest, ...
JCO Oncology Practice 19 (11_suppl), 269-269, 2023
2023
Immune-Related Adverse Events in Patients with Lung Cancer
G Sacchi de Camargo Correia, T Pai, S Li, D Connor, Y Zhao, Y Lou, ...
Current oncology reports 25 (11), 1259-1275, 2023
2023
P354: MULTI-INSTITUTIONAL STUDY EVALUATING THE IMPACT ON SURVIVAL OF NEWER TREATMENT COMBINATIONS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PHILADELPHIA CHROMOSOME POSITIVE …
T Badar, E Atallah, R Narra, A Mims, V Kota, S Desai, ...
HemaSphere 7 (S3), e9392932, 2023
2023
Effect of immunotherapy cessation without disease progression on outcomes in patients with metastatic non-small cell lung cancer.
B McKinley, S Li, N Wiest, E Butts, T Pai, J Wang, OM Mosalem, ...
Journal of Clinical Oncology 41 (16_suppl), e21156-e21156, 2023
2023
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20